Tanabe Pharma has submitted a marketing authorization application in Japan for ZYNLONTA, a treatment for relapsed or refractory diffuse large B-cell lymphoma (DLBCL), based on positive Phase 1/2 clinical trial results in Japanese patients. The drug showed a 58.1% overall response rate with no new safety concerns. Tanabe Pharma also signed an exclusive sublicensing agreement with Nippon Shinyaku to leverage their oncology expertise for commercial launch in Japan. This move supports ADC Therapeutics' plan to expand ZYNLONTA's global reach and advance regulatory and commercial milestones in the Japanese market.
ADC Therapeutics' updates on ZYNLONTA in Japan provide context for health sector activity on Pluang. For readers following health stocks, here is Pluang's market snapshot as of Oct 29, 2026 17:11 WIB: out of 150 priced US health-sector stocks, 86 rose and 57 fell. Notable movers include BFLY at USD 8.32 with a 6.53% increase and a typical hold time of 14 days, NUWE at USD 5.87 up 5.48% with 74% sell order activity and a 29-day hold time, and CLPT at USD 11.00 rising 4.17% with balanced buy/sell orders and an 11-day hold time.
Dimensional Fund Advisors Ltd. disclosed holding a 5.07% stake in Vesuvius PLC ordinary shares as of October 28, 2026. The disclosure follows regulatory requirements under the Takeover Code, indicating significant interest in the company. Dimensional...
Boralex Inc. has acquired Wind2, a UK-based renewable energy developer with about 350 MW of advanced wind projects across Scotland, England, and Wales. This acquisition strengthens Boralex's presence and capabilities in the UK, aligning with its stra...
Katapult Holdings, a technology-driven platform serving nonprime consumers, announced it will release its third quarter 2026 financial results on November 12, 2026, before the market opens. The company will hold a conference call and webcast at 8:00 ...
Lulu's Fashion Lounge Holdings, Inc. announced it will report its third quarter 2026 financial results on November 12, 2026, after market close. The company will host a live webcast and conference call for investors at 5:00 p.m. Eastern Time the same...
RadNet, Inc. announced it will hold a conference call on November 9, 2026, at 7:30 a.m. Pacific Time to discuss its third quarter financial results. Investors can join via phone or webcast, with a replay available afterward. This call provides insigh...
